Kelley, a chemist and biomedical engineer, leads the new Chan Zuckerberg Biohub Chicago and is developing new tools for the diagnosis of disease.
Advance the biosciences
University Priority
Enhancing Quality of Life
Innovation in the biosciences is essential to helping us live longer and healthier lives.
Õ¬Äи£Àûµ¼º½ scientists and researchers deliver cutting-edge treatments and cures through their pathbreaking work in synthetic biology, chemistry, cancer research, public health and more.
With collaboration across schools, campuses and partners such as Õ¬Äи£Àûµ¼º½ Medicine, a significant percentage of the University’s $1 billion research enterprise is dedicated to the biosciences. This page provides a snapshot of the transformative work taking place at Õ¬Äи£Àûµ¼º½.
Õ¬Äи£Àûµ¼º½ scientists have been blazing new trails in synthetic biology — an innovative marriage of engineering, physics and biological systems — for nearly two decades. Attracting world-class faculty and a growing NIH funding, CSB was established as a nexus of this emerging field that is poised to transform medicine, energy and more. With a recent $18.5 million grant from the U.S. Department of Energy, Õ¬Äи£Àûµ¼º½ continues to lead in this space.
Home of the blockbuster drug Lyrica®, CLP is now on an ambitious quest to sequence proteins on the scale of the Human Genome Project. Ushering in a new era of personalized medicine, the institute is at the forefront of proteomics, a revolutionary and fast-growing field that identifies and measures proteins, linking genes and diseases to diagnose and treat threats to human health.
One of the rigorously selected National Cancer Institute (NCI)-designated Comprehensive Cancer Centers, the Lurie Cancer Center has recently received NCI’s highest rating — overall “exceptional” — along with an estimated $30 million in core funding to build on its 50 years of breakthrough research leading to better ways of preventing, diagnosing and treating cancer.
A powerhouse of public health research at the Feinberg School of Medicine, IPHAM sheds critical light on societal ails ranging from health disparities to food allergies to the opioid crisis and more. Working closely with Chicago communities while uncovering data that has national impact, IPHAM changes lives every day through interdisciplinary collaborations that cut across medicine, social sciences and technology.
Meet Some of Our Experts
Õ¬Äи£Àûµ¼º½â€™s researchers make breakthroughs that advance healthcare for everyone.
With an emphasis on translational medicine, our physician-scientists and engineers are at the forefront of research and discovery.
Rivnay engineers organic and biohybrid bioelectronic materials, devices and systems for interfacing between the complex world of biology and traditional optoelectronics.
Shilatifard’s laboratory studies how Õ¬Äи£Àûµ¼º½al context alters the expression of our cellular genome and results in diseases such as cancer, neurodegenerative disorders and aging.
Highlights
Learn about Õ¬Äи£Àûµ¼º½â€™s leadership in the biosciences.
News
See Õ¬Äи£Àûµ¼º½â€™s new developments in support of this priority.
More than $6 million in strategic seed funding for Õ¬Äи£Àûµ¼º½ faculty to date accelerates high-impact research toward commercialization
Researchers develop tunable system that controls chemical transport at atomic scale
Novel, simple approach demonstrates impact of previously untapped active sites
Restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment
Scientists and engineers unlock the body’s healing powers.
The Denning Ataxia Center, part of the Feinberg Neuroscience Institute, will be dedicated to advancing the understanding, treatment and care for patients affected by ataxia.